Head-to-head · WeighScore
Risen Labs vs Tablet Health
The verdict
Risen Labs takes it — 57.2/100 to 47.6/100.
Risen Labs grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Risen Labs (risenlabstx.com, Risen Labs LLC) is a telehealth service offering compounded semaglutide and tirzepatide as once-weekly injections for weight loss, alongside men's health and hormone programs.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Risen Labs | Tablet Health |
|---|---|---|
| WeighScore | 57.2/100 | 47.6/100 |
| Grade | C | C |
| Scorecard rank | #403 | #495 |
| Semaglutide | Not disclosed | Not disclosed |
| Tirzepatide | Not disclosed | Not disclosed |
| Coverage | 2 states | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Yes |
Graded #403 · C
Strengths
- Names its compounding pharmacy (Olympia Pharmacy, a 503A compounding pharmacy) and legal entity (Risen Labs LLC)
- Offers compounded semaglutide and tirzepatide as clinician-guided once-weekly injections
- Focused clinical intake covering weight loss, men's health, and hormone protocols
Where it loses points
- GLP-1 pricing is not published; it appears only after you complete the clinical intake
- Available only to patients in New York and Colorado
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
- No LegitScript certification is displayed on the site
Graded #495 · C
Strengths
- LegitScript Certified
- Four named compounding pharmacy partners (Pharmacy Hub, Epiq Scripts, Dr. TelX, Emerad), none with FDA warning letters
- Oral GLP-1 option for both semaglutide and tirzepatide — uncommon in compounded telehealth
- Mid-tier pricing starting $179–$299/mo across all four product variants
- No commitment — cancel anytime
Where it loses points
- States served not published — you must complete the intake quiz to learn eligibility
- No founder, CEO, medical director, or pharmacist-in-charge named anywhere
- No BBB profile found
- Its Queens NYC pharmacy is 'opening soon' — all dispensing currently routes through external partners
- FDA issued this company a warning letter dated 19 March 2025; the letter is public in FDA's warning-letter database
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.